Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.

导出 OA

翻译打印收藏纠错

第一作者： Hansjürgen,Agostini

第一单位： Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

作者： Hansjürgen,Agostini ^[1] ; Francis,Abreu ^[2] ; Caroline R,Baumal ^[3] ; Dolly S,Chang ^[2] ; Karl,G Csaky ^[4] ; Anna M,Demetriades ^[5] ; Laurent,Kodjikian ^[6] ; Jennifer I,Lim ^[7] ; Philippe,Margaron ^[8] ; Jordi M,Monés ^[9] ; Tunde,Peto ^[10] ; Federico,Ricci ^[11] ; Matthias,Rüth ^[8] ; Rishi P,Singh ^[12] ; Ivaylo,Stoilov ^[2] ; Balakumar,Swaminathan ^[13] ; Jeffrey R,Willis ^[2] ; Peter D,Westenskow ^[14]

作者单位： Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. ^[1] Genentech, Inc., South San Francisco, CA, USA. ^[2] Tufts Medicine New England Eye Center, Boston, MA, USA.;Apellis Pharmaceuticals, Waltham, MA, USA. ^[3] Retina Foundation of the Southwest, Dallas, TX, USA. ^[4] Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USA. ^[5] Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France.;CNRS UMR 5510 Mateis, INSA, University of Lyon I, Villeurbanne, France. ^[6] Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, University of Illinois at Chicago, Chicago, IL, USA. ^[7] F. Hoffmann-La Roche Ltd., Basel, Switzerland. ^[8] Centro Médico Teknon, Institut de La Màcula and Barcelona Macula Foundation, Barcelona, Spain. ^[9] Centre for Public Health, Queen's University Belfast, Belfast, UK. ^[10] Department of Experimental Medicine, University "Tor Vergata", Rome, Italy. ^[11] Cleveland Clinic Florida, Stuart, FL, USA. ^[12] F. Hoffmann-La Roche Ltd., Mississauga, ON, Canada. ^[13] F. Hoffmann-La Roche Ltd., Basel, Switzerland. peter.westenskow@roche.com. ^[14]

关键词 Angiopoietin-2 Faricimab Retinal vascular disease Vascular endothelial growth factor-A Vascular stability

主题词人类(Humans);血管生成抑制剂(Angiogenesis Inhibitors);血管生成素2(Angiopoietin-2);抗体, 双特异性(Antibodies, Bispecific);糖尿病视网膜病变(Diabetic Retinopathy);玻璃体内注射(Intravitreal Injections);黄斑水肿(Macular Edema);体层摄影术, 光学相干(Tomography, Optical Coherence);治疗结果(Treatment Outcome);血管内皮生长因子A(Vascular Endothelial Growth Factor A);视敏度(Visual Acuity);湿性黄斑变性(Wet Macular Degeneration);临床试验(主题)(Clinical Trials as Topic);药物评价, 临床前(Drug Evaluation, Preclinical)

DOI 10.1007/s00417-024-06531-9

PMID 38847896

发布时间 2024-12-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

2024年262卷11期

3437-3451页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

相似文献

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

相似文献

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

相关期刊

检索历史清除